DK3651768T3 - Heterocykliske inhibitorer af atr-kinase - Google Patents
Heterocykliske inhibitorer af atr-kinase Download PDFInfo
- Publication number
- DK3651768T3 DK3651768T3 DK18831104.7T DK18831104T DK3651768T3 DK 3651768 T3 DK3651768 T3 DK 3651768T3 DK 18831104 T DK18831104 T DK 18831104T DK 3651768 T3 DK3651768 T3 DK 3651768T3
- Authority
- DK
- Denmark
- Prior art keywords
- atr kinase
- heterocyclic inhibitors
- heterocyclic
- inhibitors
- atr
- Prior art date
Links
- 108091000080 Phosphotransferase Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 102000020233 phosphotransferase Human genes 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762531951P | 2017-07-13 | 2017-07-13 | |
PCT/US2018/042128 WO2019014618A1 (en) | 2017-07-13 | 2018-07-13 | HETEROCYCLIC INHIBITORS OF KINASE ATR |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3651768T3 true DK3651768T3 (da) | 2024-03-18 |
Family
ID=64998660
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK18831104.7T DK3651768T3 (da) | 2017-07-13 | 2018-07-13 | Heterocykliske inhibitorer af atr-kinase |
Country Status (19)
Country | Link |
---|---|
US (3) | US10392376B2 (da) |
EP (1) | EP3651768B1 (da) |
JP (1) | JP7159307B2 (da) |
KR (1) | KR102676822B1 (da) |
CN (2) | CN117466884A (da) |
AU (1) | AU2018301696B8 (da) |
CA (1) | CA3069693A1 (da) |
DK (1) | DK3651768T3 (da) |
ES (1) | ES2974334T3 (da) |
FI (1) | FI3651768T3 (da) |
HU (1) | HUE066043T2 (da) |
IL (1) | IL271930B (da) |
LT (1) | LT3651768T (da) |
MX (1) | MX2020000386A (da) |
PH (1) | PH12020500072A1 (da) |
PT (1) | PT3651768T (da) |
RS (1) | RS65466B1 (da) |
SI (1) | SI3651768T1 (da) |
WO (1) | WO2019014618A1 (da) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10421765B2 (en) | 2017-05-26 | 2019-09-24 | Board Of Regents, The University Of Texas System | Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase |
RS65466B1 (sr) * | 2017-07-13 | 2024-05-31 | Univ Texas | Heterociklični inhibitori atr kinaze |
JP7290627B2 (ja) | 2017-08-17 | 2023-06-13 | ボード オブ レジェンツ,ザ ユニバーシティ オブ テキサス システム | Atrキナーゼの複素環式阻害剤 |
WO2019050889A1 (en) * | 2017-09-08 | 2019-03-14 | Bluevalley Pharmaceutical Llc | SUBSTITUTED PYRROLOPYRIDINES AS ATR INHIBITORS |
CN112218631B (zh) | 2018-03-16 | 2023-12-22 | 德州大学系统董事会 | Atr激酶的杂环抑制剂 |
JP2022503932A (ja) * | 2018-09-27 | 2022-01-12 | フォチョン・ファーマシューティカルズ・リミテッド | Retキナーゼ阻害剤としての置換イミダゾ[1,2-a]ピリジン及び[1,2,4]トリアゾロ[1,5-a]ピリジン化合物 |
KR20220016225A (ko) * | 2019-06-06 | 2022-02-08 | 베이징 타이드 파마슈티컬 코퍼레이션 리미티드 | Atr 키나제 억제제로서의 2,4,6-삼치환된 피리미딘 화합물 |
JP7418051B2 (ja) * | 2020-05-29 | 2024-01-19 | シェンチェン リンファン バイオテック カンパニー,リミティド | フルオロピロロピリジン系化合物及びその使用 |
WO2022171034A1 (zh) * | 2021-02-10 | 2022-08-18 | 江苏先声药业有限公司 | 作为hpk1抑制剂的双环类化合物及其应用 |
WO2022262143A1 (zh) * | 2021-06-17 | 2022-12-22 | 杭州中美华东制药有限公司 | 一种吡啶硼酸酯的制备方法 |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001265871A1 (en) * | 2000-04-25 | 2001-11-07 | Actelion Pharmaceuticals Ltd | Substituted sulfonylaminopyrimidines |
KR20080083188A (ko) | 2006-01-11 | 2008-09-16 | 아스트라제네카 아베 | 모르폴리노 피리미딘 유도체 및 요법에서의 그 유도체의용도 |
CA2660758A1 (en) | 2006-08-24 | 2008-02-27 | Astrazeneca Ab | Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders |
EP2064203A1 (en) | 2006-09-14 | 2009-06-03 | AstraZeneca AB | 2-benzimidaz0lyl-6-m0rph0lin0-4-piperidin-4-ylpyrimidine derivatives as pi3k and mtor inhibitors for the treatment of proliferative disorders |
MX2009010881A (es) | 2007-04-12 | 2009-12-14 | Hoffmann La Roche | Compuestos farmaceuticos. |
US20080292588A1 (en) | 2007-05-17 | 2008-11-27 | Anadys Pharmaceuticals, Inc. | 1-methyl-benzo[1,2,4]thiadiazine 1-oxide derivatives |
WO2009007748A2 (en) | 2007-07-09 | 2009-01-15 | Astrazeneca Ab | Trisubstituted pyrimidine derivatives for the treatment of proliferative diseases |
WO2009007750A1 (en) | 2007-07-09 | 2009-01-15 | Astrazeneca Ab | Morpholino pyrimidine derivatives used in diseases linked to mtor kinase and/or pi3k |
JP2010533161A (ja) | 2007-07-09 | 2010-10-21 | アストラゼネカ アクチボラグ | 化合物−946 |
AU2009220605A1 (en) | 2008-03-06 | 2009-09-11 | Msd K.K. | Alkylaminopyridine derivative |
EP2320895A2 (en) | 2008-07-03 | 2011-05-18 | Exelixis, Inc. | Cdk modulators |
US20110053923A1 (en) | 2008-12-22 | 2011-03-03 | Astrazeneca | Chemical compounds 610 |
WO2010120996A1 (en) | 2009-04-17 | 2010-10-21 | Wyeth Llc | 5,6,7,8-tetrahydropyrido[3,4-d]pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
JP2013032290A (ja) | 2009-11-20 | 2013-02-14 | Dainippon Sumitomo Pharma Co Ltd | 新規縮合ピリミジン誘導体 |
WO2011103715A1 (en) | 2010-02-25 | 2011-09-01 | Merck Sharp & Dohme Corp. | Task channel antagonists |
WO2011106276A1 (en) | 2010-02-25 | 2011-09-01 | Merck Sharp & Dohme Corp. | Task channel antagonists |
US9249129B2 (en) | 2010-03-04 | 2016-02-02 | Cellzome Limited | Morpholino substituted urea derivatives as mTOR inhibitors |
EP2569289A1 (en) | 2010-05-12 | 2013-03-20 | Vertex Pharmaceuticals Incorporated | Pyrazines useful as inhibitors of atr kinase |
SA111320519B1 (ar) | 2010-06-11 | 2014-07-02 | Astrazeneca Ab | مركبات بيريميدينيل للاستخدام كمثبطات atr |
UA112517C2 (uk) | 2010-07-06 | 2016-09-26 | Новартіс Аг | Тетрагідропіридопіримідинові похідні |
WO2012147890A1 (ja) | 2011-04-27 | 2012-11-01 | 持田製薬株式会社 | 新規アゾール誘導体 |
HUE037371T2 (hu) | 2012-12-07 | 2018-08-28 | Vertex Pharma | 2-Amino-6-fluor-N-(5-fluor-4-(4-(4-(oxetan-3-il)piperazin-1-karbonil)piperidin-1-il)piridin-3-il) pirazolo[1,5alfa]pirimidin-3-karboxamid mint ATR kináz inhibitor |
AU2014253798C1 (en) | 2013-04-19 | 2019-02-07 | Incyte Holdings Corporation | Bicyclic heterocycles as FGFR inhibitors |
SG11201604519PA (en) | 2013-12-06 | 2016-07-28 | Vertex Pharma | 2-amino-6-fluoro-n-[5-fluoro-pyridin-3-yl]pyrazolo[1,5-a]pyrimidin-3-carboxamide compound useful as atr kinase inhibitor, its preparation, different solid forms and radiolabelled derivatives thereof |
WO2015092592A1 (en) | 2013-12-17 | 2015-06-25 | Pfizer Inc. | Novel 3,4-disubstituted-1h-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7h-pyrrolo[2,3-c]pyridazines as lrrk2 inhibitors |
LT3152212T (lt) | 2014-06-05 | 2020-05-11 | Vertex Pharmaceuticals Inc. | Radioaktyviai žymėti 2-amino-6-fluor-n-[5-fluor-piridin-il]- pirazolo[1,5-a]pirimidin-3-karboksamido junginio dariniai, naudingi kaip atr kinazės inhibitoriai, minėto junginio gamybos būdas ir jo skirtingos kietos formos |
TWI656121B (zh) | 2014-08-04 | 2019-04-11 | 德商拜耳製藥公司 | 2-(嗎啉-4-基)-1,7-萘啶 |
ES2879441T3 (es) | 2014-10-13 | 2021-11-22 | Atrin Pharmaceuticals LLC | Inhibidores de proteína quinasas relacionados con ataxia telangiectasia y RAD3 (ATR) |
WO2017210545A1 (en) | 2016-06-02 | 2017-12-07 | Cadent Therapeutics, Inc. | Potassium channel modulators |
US10421765B2 (en) | 2017-05-26 | 2019-09-24 | Board Of Regents, The University Of Texas System | Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase |
RS65466B1 (sr) * | 2017-07-13 | 2024-05-31 | Univ Texas | Heterociklični inhibitori atr kinaze |
JP7290627B2 (ja) | 2017-08-17 | 2023-06-13 | ボード オブ レジェンツ,ザ ユニバーシティ オブ テキサス システム | Atrキナーゼの複素環式阻害剤 |
CN112218631B (zh) | 2018-03-16 | 2023-12-22 | 德州大学系统董事会 | Atr激酶的杂环抑制剂 |
-
2018
- 2018-07-13 RS RS20240297A patent/RS65466B1/sr unknown
- 2018-07-13 US US16/035,310 patent/US10392376B2/en active Active
- 2018-07-13 HU HUE18831104A patent/HUE066043T2/hu unknown
- 2018-07-13 IL IL271930A patent/IL271930B/en unknown
- 2018-07-13 DK DK18831104.7T patent/DK3651768T3/da active
- 2018-07-13 KR KR1020207004080A patent/KR102676822B1/ko active IP Right Grant
- 2018-07-13 CA CA3069693A patent/CA3069693A1/en active Pending
- 2018-07-13 WO PCT/US2018/042128 patent/WO2019014618A1/en active Application Filing
- 2018-07-13 FI FIEP18831104.7T patent/FI3651768T3/fi active
- 2018-07-13 EP EP18831104.7A patent/EP3651768B1/en active Active
- 2018-07-13 AU AU2018301696A patent/AU2018301696B8/en active Active
- 2018-07-13 MX MX2020000386A patent/MX2020000386A/es unknown
- 2018-07-13 JP JP2020523235A patent/JP7159307B2/ja active Active
- 2018-07-13 ES ES18831104T patent/ES2974334T3/es active Active
- 2018-07-13 LT LTEPPCT/US2018/042128T patent/LT3651768T/lt unknown
- 2018-07-13 SI SI201831077T patent/SI3651768T1/sl unknown
- 2018-07-13 CN CN202311427557.9A patent/CN117466884A/zh active Pending
- 2018-07-13 PT PT188311047T patent/PT3651768T/pt unknown
- 2018-07-13 CN CN201880051484.9A patent/CN111867590B/zh active Active
-
2019
- 2019-07-10 US US16/507,851 patent/US10800769B2/en active Active
-
2020
- 2020-01-09 PH PH12020500072A patent/PH12020500072A1/en unknown
- 2020-09-01 US US17/009,428 patent/US11434233B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
AU2018301696B8 (en) | 2023-03-23 |
CN111867590A (zh) | 2020-10-30 |
LT3651768T (lt) | 2024-04-25 |
US10800769B2 (en) | 2020-10-13 |
HUE066043T2 (hu) | 2024-07-28 |
KR20200028441A (ko) | 2020-03-16 |
PH12020500072A1 (en) | 2020-11-09 |
SI3651768T1 (sl) | 2024-05-31 |
PT3651768T (pt) | 2024-03-20 |
US10392376B2 (en) | 2019-08-27 |
KR102676822B1 (ko) | 2024-06-19 |
AU2018301696B2 (en) | 2022-10-27 |
MX2020000386A (es) | 2020-08-06 |
WO2019014618A1 (en) | 2019-01-17 |
FI3651768T3 (fi) | 2024-03-14 |
AU2018301696A1 (en) | 2020-02-27 |
JP2020527174A (ja) | 2020-09-03 |
AU2018301696A8 (en) | 2023-03-23 |
US11434233B2 (en) | 2022-09-06 |
EP3651768A4 (en) | 2021-04-07 |
IL271930B (en) | 2022-07-01 |
ES2974334T3 (es) | 2024-06-26 |
EP3651768A1 (en) | 2020-05-20 |
CA3069693A1 (en) | 2019-01-17 |
US20210047311A1 (en) | 2021-02-18 |
CN111867590B (zh) | 2023-11-17 |
IL271930A (en) | 2020-02-27 |
EP3651768B1 (en) | 2023-12-20 |
CN117466884A (zh) | 2024-01-30 |
US20190016713A1 (en) | 2019-01-17 |
US20200102296A1 (en) | 2020-04-02 |
JP7159307B2 (ja) | 2022-10-24 |
RS65466B1 (sr) | 2024-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3651768T3 (da) | Heterocykliske inhibitorer af atr-kinase | |
DK3512850T3 (da) | Inhibitorer af menin-mll-interaktionen | |
DK3710439T3 (da) | Kras g12c-hæmmere | |
DK3468966T3 (da) | Inhibitorer af menin-mll-interaktionen | |
DK3371171T3 (da) | Inhibitorer af RET | |
DK3303334T3 (da) | Tyrosinkinasehæmmere | |
DK3377059T3 (da) | Hæmmere af cxcr2 | |
DK3423451T3 (da) | Inhibitorer af wdr5-protein-proteinbinding | |
DK3442977T3 (da) | Inhibitorer af activinreceptorlignende kinase | |
DK3298002T3 (da) | Heterocykliske amider som kinasehæmmere | |
DK3102576T3 (da) | Dihydropyrrolopyridininhibitorer af ror-gamma | |
MA42242A (fr) | Inhibiteurs de la tyrosine kinase | |
DK3704120T3 (da) | Heterocykliske forbindelser som prmt5-inhibitorer | |
DK3164380T3 (da) | Hæmmere af lysinspecifik demethylase-1 | |
DK3442972T3 (da) | Bromdomænehæmmere | |
DK3160956T3 (da) | Inhibitorer af lysin-specifik demethylase-1 | |
IL279949A (en) | Heterocyclic MCT4 inhibitors | |
EP3668839A4 (en) | HETEROCYCLIC INHIBITORS OF THE ATR KINASE | |
DK3613737T3 (da) | Hidtil ukendt inhibitor af cyclin-afhængig kinase CDK9 | |
DK3457851T3 (da) | Derivater af sobetirom | |
DK3512857T3 (da) | Spiro-bicykliske inhibitorer af menin-mll-interaktion | |
DK3571192T3 (da) | Jak1-selektive inhibitorer | |
DK3215493T3 (da) | Syntese af copanlisib og dihydrochloridsalt deraf | |
DK3302550T3 (da) | Kombination af et anti-cd19 antistof og en brutons tyrosine kinase-inhibitor og anvendelse deraf | |
DK3630744T3 (da) | Pyrazol-magl-inhibitorer |